ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

NBY NovaBay Pharmaceuticals Inc New

0.088
-0.002 (-2.22%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NovaBay Pharmaceuticals Inc New NBY AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.002 -2.22% 0.088 18:39:33
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0915 0.09 0.10 0.0949 0.09
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202405:50BWNovaBay Pharmaceuticals to Hold 2024 First Quarter..
22/4/202405:57BWNovaBay Pharmaceuticals Announces New and Enhanced..
19/4/202417:00BWNovaBay Pharmaceuticals Receives a NYSE American Notice..
17/4/202405:59BWNovaBay Pharmaceuticals Reports Preliminary Eyecare and..
26/3/202415:05BWNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full..
25/3/202417:38BWNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full..
14/3/202407:00BWNovaBay Pharmaceuticals Announces Agreement to Sell its..
14/2/202413:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202410:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202408:00BWNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in..
10/1/202407:00EDGAR2Form 8-K - Current report
09/1/202408:15BWNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to..
04/1/202410:50EDGAR2Form D - Notice of Exempt Offering of Securities
21/12/202306:58EDGAR2Form 8-K - Current report
11/12/202315:32EDGAR2Form 8-K - Current report
06/12/202305:50BWNovaBay Pharmaceuticals Partners with Woo University to..
09/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:05BWNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202305:50BWNovaBay Pharmaceuticals to Hold Third Quarter 2023..
11/10/202307:00BWNovaBay Pharmaceuticals Expands Physician Dispensed Sales..
02/10/202305:50BWNovaBay Pharmaceuticals to Present at the Dawson James Small..
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
14/9/202307:00BWNovaBay Pharmaceuticals Announces Commercial Launch of..
11/9/202307:00BWNovaBay Pharmaceuticals Announces Agreement with BioStem..
10/8/202315:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:05BWNovaBay Pharmaceuticals Reports Second Quarter 2023..
08/8/202315:05BWNovaBay Pharmaceuticals to Hold Second Quarter 2023..
14/7/202307:30BWNovaBay Pharmaceuticals Reports Record Avenova Sales Day
10/7/202305:50BWNovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day..
07/7/202316:00EDGAR2Form 8-K - Current report
06/7/202316:00EDGAR2Form 8-K - Current report
28/6/202305:50BWNovaBay Pharmaceuticals Supports National Dry Eye Awareness..
20/6/202305:50BWNovaBay Pharmaceuticals to Showcase its Full Line of Avenova..
12/6/202305:50BWNovaBay Pharmaceuticals Announces DERMAdoctor’s KP Duty..
11/5/202315:05BWNovaBay Pharmaceuticals Reports First Quarter 2023 Financial..
05/5/202305:50BWPhaseOne Health Collaborates with Nonprofit Humanitarian..

Su Consulta Reciente

Delayed Upgrade Clock